Service alert

United States Loses Measles Elimination Status After More Than 25 Years

11/17/2026
Newsroom, News Releases

CAP emphasizes the critical role of laboratories in measles surveillance, diagnosis, and outbreak response 

NORTHFIELD, Ill. (November 17, 2026) — The United States has lost its measles elimination status, ending a public health achievement first established in 2000. The Pan American Health Organization (PAHO) made the determination following a review of epidemiological and laboratory evidence indicating that measles transmission has continued uninterrupted for at least 12 months. 

This means endemic measles transmission has been reestablished in the United States, highlighting the ongoing challenge of containing outbreaks and preventing further spread of the highly contagious virus. 

 “Losing measles elimination status is a significant public health setback and a reminder that sustained efforts are needed to prevent and control infectious diseases,” said Qihui “Jim” Zhai, MD, FCAP, president of the College of American Pathologists (CAP). “Laboratories play an essential role in identifying measles infections, supporting public health surveillance, and helping health officials understand and respond to outbreaks. Accurate, timely testing is essential to those efforts.” 

 Clinical diagnosis and laboratory testing are critical components of measles surveillance and outbreak response. Molecular testing can detect the measles virus and provide information that helps public health officials investigate cases and track transmission. As measles cases have increased, more laboratories have brought molecular testing in-house, helping patients and physicians receive results more quickly. Reliable diagnostic testing becomes especially important during outbreaks, when timely identification of new cases can inform public health response efforts. 

To support laboratory readiness, the CAP offers a Measles, Mumps, Rubella and Varicella-Zoster Virus (MMRV) Molecular Proficiency Testing program. The measles component includes both wild-type and vaccine-strain material, helping laboratories assess their ability to distinguish between the two. The program helps laboratories assess their testing performance for these highly-infectious diseases and strengthen their confidence in their ability to deliver accurate results when needed. 

Continued measles prevention, surveillance, and laboratory preparedness are critical to limiting further spread. Strong diagnostic capabilities and public health response systems remain essential to identifying cases and protecting communities. 

### 

 About the College of American Pathologists  

As the world’s largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide.